ALKERMES | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 16K 0 2024-12
ALKERMES USD 1.77M 4K 2024-12
Amgen USD 33.53B 140M 2024-12
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Gilead Sciences USD 1000K 0 2024-12
Intra Cellular Therapies USD 11K 0 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
J&J USD 3.12B 0 2024-12
Malin Corporation EUR 200K 0 2024-06
Merck USD 1.79B 0 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Otsuka Holdings JPY 81.69B 0 2024-12
Pfizer USD 480M 0 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Vertex Pharmaceuticals USD 2.6M 0 2024-12



ALKERMES Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.